NUMI

Numinus Wellness (NUMI.V) announced that Health Canada has cleared their MAPS-sponsored single-arm, open-label safety and feasibility study evaluating MDMA-assisted therapy for post-traumatic stress disorder (PTSD). The study is being…
“Life is too short to be small.” – Tim Ferriss, The 4-Hour Workweek Every psychedelics company starts its investor deck off with a fact about the quickly changing regulatory…
Numinus (NUMI.V)  is gaining somewhat of a cult-like following among retail investors.   People see an undervalued company with competitive advantages, and from an ethics standpoint, a company conducting…
Numinus Wellness’ (NUMI.V) compassionate-access trial for MDMA-assisted therapy has enjoyed some success in terms of treating patients with post-traumatic stress disorder (PTSD), according to a press release. The trial…
Numinus Wellness (NUMI.V) closed its previously announced acquisition of psychedelic programming operation, Mindspace Psychology Services today. Mindspace Wellbeing, the operational arm of Mindspace Psychology Services, is a well-being organization…
Numinus Wellness (NUMI.V) entered into a lab services agreement with Optimi Health to develop a functional mushroom brand for the health and wellness sector earlier this week, according to…
The notion of magic mushroom market offering after the legalization of cannabis has been floated time and again since long before cannabis legalization was even on the table. It…
Numinus Wellness (NUMI.V) finished their first legal extraction of psilocybe mushrooms in Canada for research purposes today, according to a press release. This follows the company’s completion of their…
If this was a 1990’s news website we’d be putting all sorts of animated siren gifs all over the top of this piece because, I ain’t gonna lie: It’s…
Numinus Wellness (NUMI.V) started cultivating psilocybe mushrooms for production at their 7,000 square foot Health Canada approved facility today, according to a press release. At present, therapies involving magic…